Stay updated with breaking news from Gamida Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gamida Cell Ltd. (NASDAQ:GMDA) is an Israeli-based developmental biotechnology company specializing in discovering and advancing cell therapies to fight blood cancer and other illnesses.
Gamida Cell Ltd. (NASDAQ:GMDA – Get Rating) – Equities researchers at HC Wainwright issued their FY2026 earnings per share (EPS) estimates for Gamida Cell in a research report issued to clients and investors on Wednesday, April 19th. HC Wainwright analyst V. Bernardino forecasts that the company will post earnings per share of $0.90 for the […]
Gamida Cell Ltd. , a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the launch of a follow-on public offering of its ordinary shares and accompanying warrants... | April 18, 2023
Gamida Cell (NASDAQ:GMDA – Get Rating) had its price objective hoisted by stock analysts at HC Wainwright from $5.00 to $11.00 in a research report issued to clients and investors on Wednesday, The Fly reports. Separately, Oppenheimer cut their price target on shares of Gamida Cell from $10.00 to $8.00 and set an “outperform” rating […]
Trio Petroleum Corp, an oil and gas exploration and development company focused on strategic, high growth energy projects in California, said that it priced its initial public offering of 2 million shares of its common stock at $3.